Detailed price information for Zentalis Pharmaceuticals Inc (ZNTL-Q) from The Globe and Mail including charting and trades.

Scientists in Shanghai have developed a potentially groundbreaking treatment for diabetes that targets the root cause of the disease rather than just its symptoms, offering hope for a functional cure.

Detailed price information for Theralase Technologies Inc. (TLT-X) from The Globe and Mail including charting and trades.

Full Year revenue increased 12.6% year over year to a record $427.5 millionFull Year net loss of $29.2 million, compared to net loss of $195.5 million in 2024; Non-GAAP adjusted net profit of $13.0 mi ...

RNA modifications have emerged as a crucial area of research within molecular viral pathogenesis, providing new insights into how viruses hijack host gene ...

A metabolic enzyme studied for over seven decades has a hidden second function—it can unwind RNA and promote cell cycle progression, an additional function beyond its role in energy production, ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the randomized Phase 2 FOURLIGHT-1 study evaluating atirmociclib in combination with fulvestrant, versus fulvestrant or everolimus ...

A growing field of research suggests that some medical treatments, such as cancer therapy or vaccines, might be more ...

South Korea has shut down the dog meat market. Australia could completely eliminate cervical cancer by 2028. France has ...